A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a new drug called CB03-154 to help people with epilepsy. The study aims to see if the drug is safe, how well patients can handle it, and how the body processes it. Researchers are also looking at whether taking the drug with food changes its effects.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or non-prescription drugs, including vitamins and herbal supplements, at least 7 days before the study and throughout its duration, except for acetaminophen, which is allowed in limited amounts.
Who Is on the Research Team?
Frank Lee, M.D
Principal Investigator
Frontage Clinical Services, Inc.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single and multiple ascending oral doses of CB03-154 or placebo in a fasted state for 14 consecutive days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CB03-154
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shanghai Zhimeng Biopharma, Inc.
Lead Sponsor